The QNPHC is implemented a training cours for health professionnals. The group works closely with Genome Quebec to develop a “Genomic 101″ training course for health professionals …Read More
QNPHC’s Chairman of the Board, David Levine,is pleased to announce that AstraZeneca Canada Inc is now a QNPHC new partner. Jean-Frédéric Lafontaine, represents AstraZeneca on the Board …Read More
At the international Congress on the personalized health care, held in Montreal, the June 2016 publication of “Regard sur l’industrie biopharmaceutique” writes about Personalized health care: Issues in …Read More
QNPHC’s Chairman of the Board, David Levine,is pleased to announce that Merck Canada decided to continue its financial contribution for the next three years.
Mr. Carl Viel, CEO of Québec International, is now part of QNPHC’s board of directors, representing Biopolis
QNPHC got a subsidy from the MEIE (Economy, Innovation and Exports) to meet a significant issue for companies in the sector of life science : i.e. the …Read More
The Board of Directors of the QNPHC is pleased to announce that Merck Canada Inc. has renewed its financial support for the next three years.
The QNPHC as well as several organizations dedicated to the PHC through Canada showed their interest in the creation of a Canada-wide network to promote PHC and …Read More
Mr. Carl Viel, CEO of Québec International, is now part of the QNPHC’s board, representing Biopolis.